What we know about COVID-19 and kids

It’s unusual that a virus would be less severe in children than in adults, yet that is the case with COVID-19. Yale researchers are working to understand why.
Child and health care worker in hospital room.

(© stock.adobe.com)

It’s unusual that a virus would be less severe in children than it is in adults. But when it comes to COVID-19, kids make up just a small percentage of severe cases. Yale researchers are working to understand why that is.

Their discoveries can help guide understanding of the virus and possible treatment options.

In a paper published recently in Proceedings of the National Academy of Sciences (PNAS), Dr. Naftali Kaminski, the Boehringer-Ingelheim Endowed Professor of Internal Medicine and chief of Pulmonary, Critical Care and Sleep Medicine, and colleagues shared findings related to children’s surprising immunity to the virus. They detailed how factors including allergies, asthma, the common cold, and existing vaccines may be having a protective effect. 

Meanwhile, Carrie Lucas, assistant professor of immunobiology at Yale, is looking at blood samples from the small percentage of children who develop the rare condition known as Multi-Inflammatory Syndrome in Children, or MIS-C, in response to COVID-19. Her lab is analyzing blood samples for molecular and genetic clues to figure out why a certain subset of kids are most at risk. 

Findings just published in the journal Science Translational Medicine led by Kevan Herold, the C.N.H. Long Professor of Immunology and Internal Medicine at Yale, revealed that children diagnosed with COVID-19 express higher levels of two specific immune system molecules, a factor that might be leading to better health outcomes.

Understanding why children appear to be better protected from severe cases than adults could provide important clues on how the novel coronavirus spreads, who is at greatest risk, and how to treat it. 

This is different from other viruses that affect kids more seriously,” Kaminski said. “It’s an interesting conundrum and could provide implications for therapeutics.” 

In the PNAS paper, researchers point to the possibility that allergies and asthma in children has a protective effect. When the body responds to an allergy or asthma trigger, the immune system releases Th2 cells, which in turn increases a type of cell called the eosinophil in the blood and tissues. This allergic inflammation has been shown to dramatically reduce the levels of a key receptor to the COVID-19 molecule, known as ACE2. They added that a study of 85 older adults who died of COVID-19 in China showed that they had very low levels of blood eosinophils. 

Initially, there was a concern about the impact of COVID-19 on children with asthma,” said Kaminski. Some 7.5% of U.S. children under 18, or 5.5 million kids, have asthma, according to the Centers for Disease Control and Prevention. “But, in fact, it seems that compared to other chronic lung diseases, people with asthma are infected less, and, when they are infected, asthma is not a risk factor.” 

Instead, risk factors known to drive worse COVID-19 outcomes include age, obesity, hypertension, and cardiac diseases.

The greater exposure children have to the common cold may also offer protection. Coronaviruses are a large family of viruses so named for their crown-like shape under a microscope, of which the common cold is one. SARS-CoV-2, which causes COVID-19, is another.

It is thought that exposure to colds may cause viral interference, when one virus interferes with the replication of a second virus. Exposure to common colds, and more severe illnesses like croup, more common in children, are associated with decreased expression of the ACE2 COVID-19 receptor. Studies have found that children symptomatic with COVID-19 may have high viral loads in their noses but, because they have lower levels of ACE2, their lungs are less likely to become infected. In other words, they can still easily spread the virus, but are less likely to develop serious symptoms.  

Kaminski added that there is even evidence that vaccines can provide protection. A study of Department of Defense personnel found that the 2017-2018 seasonal flu vaccine produced a “statistically significant” number of individuals who tested positive for common cold-related coronaviruses. If future flu vaccines are designed to increase common coronaviruses, he said, this phenomenon may actually provide some protection to SARS-CoV-2 through “cross-reactive immunity.”

For a rare number of kids, a severe response 

Of course, not all children are protected from the worst effects of COVID-19. Lucas and her team of pediatric immune disease researchers at Yale are looking at the rare cases of children who have been seriously affected by the virus. Specifically, they looked at children who were asymptomatic during SARS-CoV-2 infection, but weeks later developed a high fever, vomiting, abdominal pain, and sometimes shock, a condition known as MIS-C. As of Sept. 17, there were 935 confirmed cases of MIS-C in the U.S., and 19 deaths. 

Lucas’ lab, which has enrolled 16 pediatric MIS-C patients, is analyzing immune cells in their blood at the single-cell level, as well as thousands of blood proteins, to understand what is happening. 

Mostly, right now, our data are showing what the syndrome is not,” she said. “For instance, we have found no sign of an active viral or bacterial infection during acute MIS-C.”

They are also collecting saliva samples from parents to compare to children’s samples, which might reveal information about genetic variants. “We’re looking for the needle in the haystack that could be causing this rare manifestation,” Lucas said. “So far, there’s no evidence that this is something that runs in families. I don’t know of any cases where two children in a family developed MIS-C.” 

What they do know, she said, is that inflammatory markers are high, and most patients respond well to immunosuppressive therapies such as steroids. Additional findings will be published in the coming weeks on MedRxiv, a preprint server founded by Yale scientists which publishes studies before they have been peer-reviewed. 

While children largely seem to be protected from the immediate effects of COVID-19, there are still long-term concerns, Kaminski and the authors caution. The pandemic and social distancing, they note, affect maturation of the immune system, psychological health, education, and childhood obesity. 

We know that the health of children is strongly affected by socioeconomic downturns,” Kaminski said, “and this potential adverse outcome should not be overlooked.”

Share this with Facebook Share this with X Share this with LinkedIn Share this with Email Print this
Part of the In Focus Collection: Yale responds to COVID-19

Media Contact

Fred Mamoun: fred.mamoun@yale.edu, 203-436-2643